deferoxamine and amphotericin b

deferoxamine has been researched along with amphotericin b in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (11.11)	18.7374
1990's	2 (22.22)	18.2507
2000's	2 (22.22)	29.6817
2010's	3 (33.33)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Gehrke, SS; Hider, RC; Pinto, EG; Pleban, K; Steverding, D; Tempone, AG; Wagner, GK	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Alemar, G; Anand, VK; Griswold, JA	1
Bisschop, P; Collart, F; Devriendt, J; Douat, N; Dratwa, M; Telerman-Toppet, N; Wens, R	1
Boelaert, JR; Van Cutsem, J	1
Asmar, P; Barratt, DM; Garcia-Covarrubias, L; Metzinger, SE; Nolan, T; Trahan, C; Van Meter, K	1
Farmaki, E; Kefala-Agoropoulou, K; Roilides, E; Tsiouris, J; Velegraki, A	1
Chayakulkeeree, M; Pati, N; Tangkoskul, T; Thamlikitkul, V; Tiengrim, S; Waywa, D	1

Reviews

2 review(s) available for deferoxamine and amphotericin b

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Intracranial complications of mucormycosis: an experimental model and clinical review. The Laryngoscope, 1992, Volume: 102, Issue:6 Topics: Adult; Alloxan; Amphotericin B; Animals; Brain Abscess; Brain Diseases; Child; Deferoxamine; Diabetes Mellitus, Experimental; Disease Susceptibility; Ethmoid Sinus; Female; Humans; Male; Mice; Mice, Inbred Strains; Middle Aged; Mucormycosis; Paranasal Sinus Diseases; Rhizopus	1992

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Intracranial complications of mucormycosis: an experimental model and clinical review.

The Laryngoscope, 1992, Volume: 102, Issue:6

Topics: Adult; Alloxan; Amphotericin B; Animals; Brain Abscess; Brain Diseases; Child; Deferoxamine; Diabetes Mellitus, Experimental; Disease Susceptibility; Ethmoid Sinus; Female; Humans; Male; Mice; Mice, Inbred Strains; Middle Aged; Mucormycosis; Paranasal Sinus Diseases; Rhizopus

1992

Other Studies

7 other study(ies) available for deferoxamine and amphotericin b

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Conjugation to 4-aminoquinoline improves the anti-trypanosomal activity of Deferiprone-type iron chelators. Bioorganic & medicinal chemistry, 2013, Feb-01, Volume: 21, Issue:3 Topics: Aminoquinolines; Antiprotozoal Agents; Deferiprone; Dose-Response Relationship, Drug; Iron Chelating Agents; Leishmania infantum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyridones; Structure-Activity Relationship; Trypanosoma brucei brucei; Trypanosoma cruzi	2013
Rhinocerebral mucormycosis in haemodialysis patients treated with desferrioxamine: possible role of recent surgery as an additional risk factor. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1991, Volume: 6, Issue:9 Topics: Amphotericin B; Brain Diseases; Deferoxamine; Humans; Male; Middle Aged; Mucormycosis; Nasal Mucosa; Postoperative Complications; Renal Dialysis	1991
Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis). Kidney international, 1989, Volume: 36, Issue:6 Topics: Amphotericin B; Animals; Deferoxamine; Ferric Compounds; Guinea Pigs; Iron; Iron Chelating Agents; Male; Mucormycosis; Rhizopus; Stimulation, Chemical	1989
Hyperbaric oxygen as an adjunct in zygomycosis: randomized controlled trial in a murine model. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:12 Topics: Amphotericin B; Animals; Antifungal Agents; Combined Modality Therapy; Deferoxamine; Female; Hyperbaric Oxygenation; Mice; Mucormycosis; Rhizopus; Survival Analysis	2001
Cutaneous zygomycosis in an infant with Pearson syndrome. Pediatric blood & cancer, 2008, Volume: 50, Issue:4 Topics: Amphotericin B; Anemia, Neonatal; Anemia, Sideroblastic; Antifungal Agents; Catheters, Indwelling; Deferoxamine; Dermatomycoses; DNA, Mitochondrial; Female; Hemochromatosis Protein; Heterozygote; Histocompatibility Antigens Class I; Humans; Infant; Infant, Newborn; Membrane Proteins; Metabolic Diseases; Methylprednisolone; Mitochondrial Diseases; Siderophores; Zygomycosis	2008
Impact of iron chelators on growth and expression of iron-related genes of Cryptococcus species. Journal de mycologie medicale, 2020, Volume: 30, Issue:1 Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Deferasirox; Deferoxamine; Drug Synergism; Fungal Capsules; Gene Expression Regulation, Fungal; Humans; Invasive Fungal Infections; Iron; Iron Chelating Agents; Iron Overload; Metabolic Networks and Pathways; Microbial Sensitivity Tests; Virulence Factors	2020